Dosing regimens associated with extended release paliperidone injectable formulations
US11324751B1 · kind B1 · utility
2Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2021 |
| Grant date | May 10, 2022 |
| Priority date | — |
| Expiry date | May 7, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.